12.355.00% ( -0.65 )
Delay Closed: Nov 20, 15:00:00Valuation
Current ValuationThe current P/E ratio is 19.38, within the reasonable range, cheaper than 68.33% of the time in the past 5 years, and the industry ranks 22/158, the industry Median 29.16.
19.38xP/E
¥12.35Stock price
¥0.64Earnings per share
19.38xP/E
Stock price¥12.35Earnings per share¥0.64
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 27.20x
- Typical range
- 14.24x–44.03x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 29.16x
08162432
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 29.16x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
600309SHwanhua | 11.39x | 62.66% | ¥216.69B |
002001SZNHU | 10.61x | 16.74% | ¥77.54B |
002460SZGanfeng Lithium | 10.52x | 271.56% | ¥69.44B |
002466SZTLC | 9.28x | 1,321.14% | ¥54.60B |
603659SHPutailai | 13.38x | 34.45% | ¥39.28B |
300037SZCAPCHEM | 19.67x | 97.44% | ¥37.20B |
600352SHZhejiang Longsheng | 16.38x | 67.91% | ¥34.09B |
600884SHNBSS | 15.22x | 208.80% | ¥21.69B |
600873SHMEIHUABIO;Mei Hua Group | 19.76x | 70.94% | ¥19.12B |
000830SZLUXI CHEMICAL | 18.47x | 82.77% | ¥18.64B |
002240SZChengxin Lithium | 13.68x | 319.39% | ¥14.99B |
002250SZLIANHE TECHNOLOGY | 19.38x | 73.54% | ¥11.11B |
002440SZRTGF | 7.53x | 79.51% | ¥10.52B |
300910SZRichful | 13.51x | 16.11% | ¥9.01B |
688353SHHSC | 14.70x | 11,075.00% | ¥8.50B |
301292SZHi-Tech Spring | 13.70x | -- | ¥7.93B |
301216SZWankai | 7.27x | 464.29% | ¥7.31B |
300641SZZHENGDANCHEM | 18.84x | -- | ¥5.78B |
603181SHHuangma Technology | 13.59x | 15.13% | ¥5.65B |
688093SHSHIHUA | 19.07x | 53.02% | ¥4.50B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
